Ipilimumab trials for Colorectal cancer

All Ipilimumab trials · All Colorectal cancer trials

Phase breakdown

Recruiting trials studying Ipilimumab for Colorectal cancer

• A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
  NCT06362369 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Immunotherapy in Patients With Early dMMR Rectal Cancer
  NCT05732389 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
  NCT06047379 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
  NCT05176483 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 244 locations

Common questions

How many trials study Ipilimumab for Colorectal cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.